1. Home
  2. XNCR vs IBTA Comparison

XNCR vs IBTA Comparison

Compare XNCR & IBTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • IBTA
  • Stock Information
  • Founded
  • XNCR 1997
  • IBTA 2011
  • Country
  • XNCR United States
  • IBTA United States
  • Employees
  • XNCR N/A
  • IBTA N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • IBTA
  • Sector
  • XNCR Health Care
  • IBTA
  • Exchange
  • XNCR Nasdaq
  • IBTA Nasdaq
  • Market Cap
  • XNCR 1.1B
  • IBTA 926.1M
  • IPO Year
  • XNCR 2013
  • IBTA 2024
  • Fundamental
  • Price
  • XNCR $13.86
  • IBTA $28.29
  • Analyst Decision
  • XNCR Buy
  • IBTA Hold
  • Analyst Count
  • XNCR 11
  • IBTA 9
  • Target Price
  • XNCR $23.50
  • IBTA $38.75
  • AVG Volume (30 Days)
  • XNCR 1.5M
  • IBTA 270.5K
  • Earning Date
  • XNCR 11-05-2025
  • IBTA 11-12-2025
  • Dividend Yield
  • XNCR N/A
  • IBTA N/A
  • EPS Growth
  • XNCR N/A
  • IBTA 2512.20
  • EPS
  • XNCR N/A
  • IBTA 2.84
  • Revenue
  • XNCR $150,132,000.00
  • IBTA $367,604,000.00
  • Revenue This Year
  • XNCR $22.09
  • IBTA N/A
  • Revenue Next Year
  • XNCR N/A
  • IBTA $0.58
  • P/E Ratio
  • XNCR N/A
  • IBTA $10.22
  • Revenue Growth
  • XNCR 38.16
  • IBTA 3.49
  • 52 Week Low
  • XNCR $6.92
  • IBTA $22.50
  • 52 Week High
  • XNCR $27.24
  • IBTA $79.80
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 54.01
  • IBTA 33.50
  • Support Level
  • XNCR $13.30
  • IBTA $32.06
  • Resistance Level
  • XNCR $15.16
  • IBTA $35.23
  • Average True Range (ATR)
  • XNCR 1.14
  • IBTA 1.24
  • MACD
  • XNCR -0.18
  • IBTA -0.70
  • Stochastic Oscillator
  • XNCR 50.22
  • IBTA 5.12

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About IBTA Ibotta Inc. Class A Common Stock

Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).

Share on Social Networks: